tags:: paper
link:: [LINK](https://www.frontiersin.org/articles/10.3389/fimmu.2020.594212/full)
authors:: Zhou P, Chen D, Zhu B, Chen W, Xie Q, Wang Y, Tan Q, Yuan B, Zuo X, Huang C, Zhu H, Li G
n:: 9
dose-cgy:: 60
time-post-rt:: within a week
disease-site:: lung cancer
pub-date:: 2021
tissue-pre-rt:: biopsy
tissue-post-rt:: biopsy
fractionation:: 10
deg-comparison:: paired pre/post same patient

- ### Demographics
	- Thirteen patients aged 43â€“68 years were included. They had histologically documented malignant tumor, recurrent or metastatic; World Health Organization (WHO) performance status score of 0 to 2; life expectancy of at least 3 months at day 1; and indication for local radiotherapy. Four patients had metastatic lung tumor from colorectal carcinoma (CRC), seven had NSCLC, one had metastatic esophageal carcinoma in the lungs, and one had metastatic cervical cancer in the lungs.
-